Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

British Journal of Cancer
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. british journal of cancer
  3. regular article
  4. article
Inducible nitric oxide synthase (iNOS) expression may predict distant metastasis in human melanoma
Download PDF
Download PDF
  • Regular Article
  • Open access
  • Published: 26 February 1999

Inducible nitric oxide synthase (iNOS) expression may predict distant metastasis in human melanoma

  • W Tschugguel1,
  • T Pustelnik2,
  • H Lass1,
  • M Mildner3,
  • W Weninger3,
  • C Schneeberger1,
  • B Jansen2,4,
  • E Tschachler3,
  • T Waldhör5,
  • J C Huber1 &
  • …
  • H Pehamberger2 

British Journal of Cancer volume 79, pages 1609–1612 (1999)Cite this article

  • 926 Accesses

  • 34 Citations

  • Metrics details

This article has been updated

Summary

Expression of inducible nitric oxide synthase (iNOS) and its cellular localization was investigated in subcutaneous or lymph node metastases of human melanoma. Immunohistochemistry revealed that iNOS expression was limited to melanoma cells. In samples of patients without distant metastases, the number of iNOS+ tumour cells/total tumour cells was 55% ± 17% (n = 12) compared with 9% ± 8% when distant metastases of lung, liver or brain occurred within an observation period of 3 years (n = 10) (P < 0.001). Western blotting confirmed the expression of iNOS protein in select cases. Notably, iNOS is expressed in regional melanoma metastases and its expression is inversely related to the tumour’s metastatic potential. Thus, iNOS expression may have predictive value for the development of distant metastases of human melanoma.

Similar content being viewed by others

Inhibition of interferon-gamma-stimulated melanoma progression by targeting neuronal nitric oxide synthase (nNOS)

Article Open access 01 February 2022

Orthotopic model for the analysis of melanoma circulating tumor cells

Article Open access 03 April 2024

Relative expression orderings based prediction of treatment response to Anti-PD-1 immunotherapy in advanced melanoma

Article Open access 25 March 2025

Article PDF

Change history

  • 16 November 2011

    This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication

References

  • Dong, Z., Staroselsky, A. H., Qi, X., Xie, K. & Fidler, I. J. (1994). Inverse correlation between expression of inducible nitric oxide synthase activity and production of metastases in K-1735 murine melanoma cells. Cancer Res 54: 789–793.

    CAS  PubMed  Google Scholar 

  • Koura, A. N., VanGolen, K., Tsan, R., Radinsky, R., Price, J. E. & Ellis, L. M. (1997). Regulation of genes associated with angiogenesis, growth, and metastasis by specific p53 point mutations in a murine melanoma cell line. Oncol Rep 4: 475–479.

    CAS  PubMed  Google Scholar 

  • Meßmer, U. K., Ankarcrona, M., Nicotera, P. & Brüne, B. (1994). p53 expression in nitric oxide-induced apoptosis. FEBS Lett 355: 23–26.

    Article  PubMed  Google Scholar 

  • Moncada, S., Palmer, R. M. J. & Higgs, E. A. (1991). Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109–142.

    CAS  PubMed  Google Scholar 

  • Nathan, C. & Xie, Q. W. (1994). Regulation of biosynthesis of nitric oxide. J Biol Chem 269: 13725–13728.

    CAS  PubMed  Google Scholar 

  • Schmidt, H.H.H.W. & Walter, U. (1994). NO at work. Cell 78: 919–925.

    Article  CAS  PubMed  Google Scholar 

  • Pammer, J., Plettenberg, A., Weninger, W., Diller, B., Mildner, M., Uthman, A., Issing, W., Stürzl, M. & Tschachler, E. (1996). CD40 antigen is expressed by endothelial cells and tumor cells in Kaposi’s sarcoma. Am J Pathol 148: 1387–1396.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Thomsen, L. L., Lawton, F. G., Knowles, R. G., Beesley, J. E., Riveros-Moreno, V. & Moncada, S. (1994). Nitric oxide synthase activity in human gynecological cancer. Cancer Res 54: 1352–1354.

    CAS  PubMed  Google Scholar 

  • Thomsen, L. L., Miles, D. W., Happerfield, L., Bobrow, L. G., Knowles, R. G. & Moncada, S. (1995). Nitric oxide synthase activity in human breast cancer. Br J Cancer 72: 41–44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tschugguel, W., Knogler, W., Czerwenka, K., Mildner, M., Weninger, W., Zeillinger, R. & Huber, J. C. (1996). Presence of endothelial calcium-dependent nitric oxide synthase in breast apocrine metaplasia. Br J Cancer 74: 1423–1426.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Xie, K., Huang, S., Dong, Z., Juang, S. H., Gutman, M., Xie, Q. W., Nathan, C. & Fidler, I. J. (1995). Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastases by K-1735 murine melanoma cells. J Exp Med 181: 1333–1343.

    Article  CAS  PubMed  Google Scholar 

  • Xie, K., Dong, Z. & Fidler, I. J. (1996). Activation of nitric oxide synthase gene for inhibition of cancer metastasis. J Leukoc Biol 59: 797–803.

    Article  CAS  PubMed  Google Scholar 

  • Xie, K., Wang, Y. F., Huang, S. Y., Xu, L., Bielenberg, D., Salas, T., McConkey, D. J., Jiang, W. D. & Fidler, I. J. (1997). Nitric oxide mediated apoptosis of K 1735 melanoma cells is associated with downregulation of Bcl 2. Oncogene 15: 771–779.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gynaecological Endocrinology and Reproductive Medicine, Department of Gynaecology and Obstetrics, University of Vienna, School of Medicine, Währinger Gürtel 18–20, Vienna, A-1090, Austria

    W Tschugguel, H Lass, C Schneeberger & J C Huber

  2. Division of General Dermatology, University of Vienna, School of Medicine, Währinger Gürtel 18–20, Vienna, A-1090, Austria

    T Pustelnik, B Jansen & H Pehamberger

  3. Division of Immunology, Department of Dermatology, Allergy and Infectious Diseases, University of Vienna, School of Medicine, Währinger Gürtel 18–20, Vienna, A-1090, Austria

    M Mildner, W Weninger & E Tschachler

  4. Department of Clinical Pharmacology;, University of Vienna, School of Medicine, Währinger Gürtel 18–20, Vienna, A-1090, Austria

    B Jansen

  5. Institute for Tumour Biology and Cancer Research, University of Vienna, School of Medicine, Währinger Gürtel 18–20, Vienna, A-1090, Austria

    T Waldhör

Authors
  1. W Tschugguel
    View author publications

    Search author on:PubMed Google Scholar

  2. T Pustelnik
    View author publications

    Search author on:PubMed Google Scholar

  3. H Lass
    View author publications

    Search author on:PubMed Google Scholar

  4. M Mildner
    View author publications

    Search author on:PubMed Google Scholar

  5. W Weninger
    View author publications

    Search author on:PubMed Google Scholar

  6. C Schneeberger
    View author publications

    Search author on:PubMed Google Scholar

  7. B Jansen
    View author publications

    Search author on:PubMed Google Scholar

  8. E Tschachler
    View author publications

    Search author on:PubMed Google Scholar

  9. T Waldhör
    View author publications

    Search author on:PubMed Google Scholar

  10. J C Huber
    View author publications

    Search author on:PubMed Google Scholar

  11. H Pehamberger
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/

Reprints and permissions

About this article

Cite this article

Tschugguel, W., Pustelnik, T., Lass, H. et al. Inducible nitric oxide synthase (iNOS) expression may predict distant metastasis in human melanoma. Br J Cancer 79, 1609–1612 (1999). https://doi.org/10.1038/sj.bjc.6690256

Download citation

  • Received: 10 February 1998

  • Accepted: 13 July 1998

  • Published: 26 February 1999

  • Issue date: 01 March 1999

  • DOI: https://doi.org/10.1038/sj.bjc.6690256

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Keywords

  • nitric oxide
  • human melanoma
  • metastasis

This article is cited by

  • Inducible nitric oxide synthase mediates DNA double strand breaks in Human T-Cell Leukemia Virus Type 1-induced leukemia/lymphoma

    • Hicham H Baydoun
    • Mathew A Cherian
    • Lee Ratner

    Retrovirology (2015)

  • Nitric oxide: role in tumour biology and iNOS/NO-based anticancer therapies

    • Simendra Singh
    • Alok K. Gupta

    Cancer Chemotherapy and Pharmacology (2011)

  • Main roads to melanoma

    • Giuseppe Palmieri
    • Mariaelena Capone
    • Paolo A Ascierto

    Journal of Translational Medicine (2009)

  • Inducible nitric oxide synthase expression in melanoma: implications in lymphangiogenesis

    • Daniela Massi
    • Maria C De Nisi
    • Clelia Miracco

    Modern Pathology (2009)

Download PDF

Advertisement

Explore content

  • Research articles
  • Reviews & Analysis
  • News & Comment
  • Current issue
  • Collections
  • Follow us on Twitter
  • Sign up for alerts
  • RSS feed

About the journal

  • Journal Information
  • Open access publishing
  • About the Editors
  • Contact
  • Special Issues
  • For Advertisers
  • Subscribe

Publish with us

  • For Authors & Referees
  • Language editing services
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

British Journal of Cancer (Br J Cancer)

ISSN 1532-1827 (online)

ISSN 0007-0920 (print)

nature.com sitemap

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2025 Springer Nature Limited